Puma Biotechnology, Inc.

PBYI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2014 Mar 2014 Dec 2013 Sep 2013 Jun 2013 Mar 2013 Dec 2012 Sep 2012
Assets
Cash & Equivalents $55.4M $163.4M $43.0M $51.3M $60.9M $91.6M $137.4M $33.3M
Accounts Receivable — — — — — — — —
Inventory — — — — — — — —
Total Current Assets $183.6M $211.7M $96.4M $110.6M $123.4M $138.2M $149.0M $34.1M
Property, Plant & Equipment $1.9M $1.8M $1.7M $1.6M $1.6M $1.6M $1.5M $1.2M
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $196.1M $220.3M $104.4M $115.1M $128.0M $141.0M $151.7M $36.5M
Liabilities
Accounts Payable $18.8M $15.2M $10.7M $9.7M $7.6M $6.9M $482.0K $1.0M
Total Current Liabilities $27.9M $20.2M $19.3M $19.2M $19.8M $21.6M $21.7M $26.7M
Long-Term Debt — — — — — — — —
Total Liabilities $29.0M $21.5M $20.4M $20.3M $21.0M $22.7M $22.8M $27.5M
Stockholders' Equity
Retained Earnings — — $-139.3M — — — — —
Total Stockholders' Equity $167.0M $198.8M $84.0M $94.8M $107.0M $118.3M $128.9M $9.0M
← Newer Page 7 of 8 Older →